Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments
Genenta Science is shifting focus to the defense industry, planning significant investments in acquisitions and growth. This strategic move, especially funding ATC in tactical systems, could enhance shareholder value and improve market positioning, despite existing financial challenges.
View signal analysis